Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Kasey, I would concur with ex and add too many unknowns and risk (both to children and NWBO) to pursue at this time. May learn more from the upcoming CI combo trial to help reduce the medical risk let's hope so.
Another possible and similar way to look at the combo trial. Is if they are going to experience an AE/SAE within the cranial cavity it would be with this combo. Which would allow (assumption) them to back off the CI if an event were to arise. Seems they expect to recruit fairly rapidly. Could be the expectation of efficacy which they hope to build upon with the addition of CI would fill the recruitment quickly IMHO.
No doubt.
Good find and agree it is at least interesting.
Mostly down day. IMUC certainly has lost that loving feeling......
Senti, I see you beat me to the punch and stickied TC's post. I like having both Flip's and TC's up at same time as they provide context between one another. (This should also help cement TC's role, which I know he relishes, as the Clinicaltrials site expert. Now he can explain both the update date at bottom of page and the references to "Lung" cancer vaccine.....when not deciphering Woody's 13g's for the board) :)
That was timely I must say.Good for her.
Me thinks acquisition. We'll see.......
Action on IMUC this afternoon. Don't know what it is about.
Might be more errors on the clinicaltrials site besides "lung" too. Wouldn't spend too much effort either way at this juncture.
Flip, Your MRK/BMS (BMY) sticky is getting long in the tooth. (You've handled a fair amount of conjecture from that sticky well.). If the clinical trials site gets corrected I'll replace with TC's post unless other news supersedes.
Need to get clinical trial site corrected first the phII is for GBM. Having "Lung" identified with "L" is confusing as "L" is not there......yet. Let's see how long it takes to get corrected. This error is not on NWBO IMO.
Having a little fun relative to the "bear" connotation on a stock message board. Been to UC Berkley once for a meeting between academia and industry at LBNL. Must admit my inner geek was jazzed visiting the iconic national lab that played a key role in some of the 20th century's scientific history. Not to mention fostered a notable share of Nobel laureates.
Glad it's John Smyth and not John Smith.
The Bears won........
Thanks, John. Interesting to watch things unfold knowing serveral here independently through their own dd have identified Germany as an additional center that is moving the ball for positive yardage. Have not seen anything out of Germany of late (or ever) that would dissuade anyone's dd.
"E ticket" for those above a certain age
Kings too.
The crossover IMO.
Those sites may have been in the pipeline (not drawing any conclusions). Something to ponder further if the German initiated the hold perhaps they were aware of the strengths and/or limitations of "L". Have the Germans initiated any new studies conceivably to address the limitations?
Pretty sure those living longer are aware of that fact regardless of the blind and/or LL statement.
Take care China.
Well its turning out to be a "good" attention getter with some new fly-by traffic. ("good" at attracting not that the attention itself is "good")
It's not like ihub to have hosting (or a host of) issues.
It's down .01 right now. Something screwed up on ihub showing down nearly $5.
Yes. Fall 2015 everyone is living longer now December 2016 and everyone is still living longer. I'd be a little frustrated at the bureaucratic status quo too.
Clay, Will you be doing the OTC thing?
We may find out. Diver had good post 87818 that touches on this aspect. I agree with his post except this has been better than some of the cinema I've been subjected to of late (from a pure entertainment perspective). If manipulation is exposed I would hope it would not overshadow the science (assuming the science is sound) and more importantly the perseverance behind the science.
Good stuff, thanks.
Clay, Will you be charting OTC stocks too?
I agree. The only point I wanted to make was NW had some possible other sources from which he may have obtained material information those being attorney David Kelley and the Freeh group which Woodford retained for "risk management".
Woodford requested Elliot Leary be appointed to board from the Freeh Group to head the investigation.
The attached mentions it and that he retained David Kelley. I think there are other articles with more details, but this is what I found with a quick search. I would also agee with biosectinvestor that it is not much of an investigation, but maintain it is another possible source for material information.
http://www.thisismoney.co.uk/money/markets/article-3361523/Has-fund-boss-fortune-lost-Midas-touch-FBI-agent-mafia-busting-lawyer-120-punt-went-sour-city-legend-Neil-Woodford.html
Also in posts from mid December 2015
Suspect the medical community/FDA (and BP) want to ascertain what CI are capable of achieving as a first line mono-therapy. As the second line of autologous (Car-T, Dendritic) CI combo-therapies adds more complexity, cost and/or risk.
NW is/was running a parallel investigation so add this to the sources that make material information a real possibility.
Agree and also thoughtful.
Well said. Thoughtful and thought provoking.
A Big Time outfit shorting their web hosting........hope the refuting of their allegations becomes a document of record.
Also think it wise to test CI combo outside the cranial cavity first as it should aid in dialing in the dosing to avoid or minimize the possibility of AE. An AE event in this trial would be less threatening than in a GBM trial.